Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Annals of Neurology
|
April 21, 2007
New natural history of interferon-beta-treated relapsing multiple sclerosis
Maria Trojano, Fabio Pellegrini, Aurora Fuiani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2010
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis
Antonio Giorgio, Emilio Portaccio, Maria Laura Stromillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosis
Roberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Brain : a Journal of Neurology
|
July 4, 2006
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
Nicola De Stefano, Marco Battaglini, M L Stromillo, et al.
Archives of Neurology
|
August 19, 2007
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis
Maria Pia Amato, Emilio Portaccio, Benedetta Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 8, 2009
APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis
Emilio Portaccio, Benedetta Goretti, Valentina Zipoli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 16, 2007
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score
Roberto Bergamaschi, Silvana Quaglini, Maria Trojano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 24, 2010
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
Maria P Amato, Emilio Portaccio, Benedetta Goretti, et al.
Journal of the Neurological Sciences
|
February 14, 2006
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta
Pasquale Annunziata, Antonio Giorgio, Lorenzo De Santi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 13, 2023
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study
Giancarlo Comi, Letizia Leocani, Luigi Ferini-Strambi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Annals of Neurology
|
April 21, 2007
New natural history of interferon-beta-treated relapsing multiple sclerosis
Maria Trojano, Fabio Pellegrini, Aurora Fuiani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 31, 2010
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis
Antonio Giorgio, Emilio Portaccio, Maria Laura Stromillo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 2, 2012
Immunomodulatory therapies delay disease progression in multiple sclerosis
Roberto Bergamaschi, Silvana Quaglini, Eleonora Tavazzi, et al.
Brain : a Journal of Neurology
|
July 4, 2006
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
Nicola De Stefano, Marco Battaglini, M L Stromillo, et al.
Archives of Neurology
|
August 19, 2007
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis
Maria Pia Amato, Emilio Portaccio, Benedetta Goretti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 8, 2009
APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis
Emilio Portaccio, Benedetta Goretti, Valentina Zipoli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 16, 2007
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score
Roberto Bergamaschi, Silvana Quaglini, Maria Trojano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 24, 2010
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
Maria P Amato, Emilio Portaccio, Benedetta Goretti, et al.
Journal of the Neurological Sciences
|
February 14, 2006
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta
Pasquale Annunziata, Antonio Giorgio, Lorenzo De Santi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 13, 2023
Impact of treatment with dimethyl fumarate on sleep quality in patients with relapsing-remitting multiple sclerosis: A multicentre Italian wearable tracker study
Giancarlo Comi, Letizia Leocani, Luigi Ferini-Strambi, et al.
Page
of 4